参考文献/References:
[1]Forman BM,Goode E,Chen J,et al.Identification of a nuclear receptor that is activated by farnesol metabolites[J].Cell,1995,81(5):687-693.[2]Han CY.Update on FXR Biology: Promising Therapeutic Target?[J].Int J Mol Sci,2018,19(7):2069.[3]Otte K,Kranz H,Kober I,et al.Identification of farnesoid X receptor beta as a novel mammalian nuclear receptor sensing lanosterol[J].Mol Cell Biol,2003,23(3):864-872.[4]Zhang Y,Kast-Woelbern HR,Edwards PA.Natural structural variants of the nuclear receptor farnesoid X receptor affect transcriptional activation[J].J Biol Chem,2003,278(1):104-110.[5]Weikum ER,Liu X,Ortlund EA.The nuclear receptor superfamily: A structural perspective[J].Protein Sci,2018,27(11):1876-1892.[6]Jiang L,Zhang H,Xiao D,et al.Farnesoid X receptor (FXR): Structures and ligands[J].Comput Struct Biotechnol J,2021,19:2148-2159.[7]Hebanowska A.Mechanisms of bile acid biosynthesis regulation--autoregulation by bile acids[J].Postepy Biochem,2011,57(3):314-323.[8]Lende M,Rijhsinghani A.Gestational Diabetes: Overview with Emphasis on Medical Management[J].Int J Environ Res Public Health,2020,17(24):9573.[9]Halilbasic E,Fuchs C,Traussnigg S,et al.Farnesoid X Receptor Agonists and Other Bile Acid Signaling Strategies for Treatment of Liver Disease[J].Dig Dis,2016,34(5):580-588.[10]Bogatyrev SR,Rolando JC,Ismagilov RF.Self-reinoculation with fecal flora changes microbiota density and composition leading to an altered bile-acid profile in the mouse small intestine[J].Microbiome,2020,8(1):19.[11]Fiorucci S,Distrutti E.The Pharmacology of Bile Acids and Their Receptors[J].Handb Exp Pharmacol,2019,256:3-18.[12]Shapiro H,Kolodziejczyk AA,Halstuch D,et al.Bile acids in glucose metabolism in health and disease[J].J Exp Med,2018,215(2):383-396.[13]Senat MV,Deruelle P.Gestational diabetes mellitus[J].Gynecol Obstet Fertil,2016,44(4):244-247.[14]Zhang HM,Wang X,Wu ZH,et al.Beneficial effect of farnesoid X receptor activation on metabolism in a diabetic rat model[J].Mol Med Rep,2016,13(3):2135-2142.[15]Zhao T,Wang J,He A,et al.Mebhydrolin ameliorates glucose homeostasis in type 2 diabetic mice by functioning as a selective FXR antagonist[J].Metabolism,2021,119:154771.[16]Fiorucci S,Distrutti E,Carino A,et al.Bile acids and their receptors in metabolic disorders[J].Prog Lipid Res,2021,82:101094.[17]Zhang F,Yuan W,Wei Y,et al.The alterations of bile acids in rats with high-fat diet/streptozotocin-induced type 2 diabetes and their negative effects on glucose metabolism[J].Life Sci,2019,229:80-92.[18]Thakkar N,Slizgi JR,Brouwer KLR.Effect of Liver Disease on Hepatic Transporter Expression and Function[J].J Pharm Sci,2017,106(9):2282-2294.[19]Seok S,Sun H,Kim YC,et al.Defective FXR-SHP Regulation in Obesity Aberrantly Increases miR-802 Expression, Promoting Insulin Resistance and Fatty Liver[J].Diabetes,2021,70(3):733-744.[20]Zhao L,Xuan Z,Song W,et al.A novel role for farnesoid X receptor in the bile acid-mediated intestinal glucose homeostasis[J].J Cell Mol Med,2020,24(21):12848-12861.[21]Liu C,Gao J,Liu J,et al.Intrahepatic cholestasis of pregnancy is associated with an increased risk of gestational diabetes and preeclampsia[J].Ann Transl Med,2020,8(23):1574.[22]Pathak P,Xie C,Nichols RG,et al.Intestine farnesoid X receptor agonist and the gut microbiota activate G-protein bile acid receptor-1 signaling to improve metabolism[J].Hepatology,2018,68(4):1574-1588.[23]Zheng X,Huang F,Zhao A,et al.Bile acid is a significant host factor shaping the gut microbiome of diet-induced obese mice[J].BMC Biol,2017,15(1):120.[24]Sun L,Xie C,Wang G,et al.Gut microbiota and intestinal FXR mediate the clinical benefits of metformin[J].Nat Med,2018,24(12):1919-1929.[25]Jiang C,Xie C,Lv Y,et al.Intestine-selective farnesoid X receptor inhibition improves obesity-related metabolic dysfunction[J].Nat Commun,2015,6:10166.[26]Fiorucci S,Distrutti E,Carino A,et al.Bile acids and their receptors in metabolic disorders[J].Prog Lipid Res,2021,82:101094.[27]Song Q,Wang L,Liu H,et al.Maternal GDM Status, Genetically Determined Blood Glucose, and Offspring Obesity Risk: An Observational Study[J].Obesity (Silver Spring),2021,29(1):204-212.[28]Heidker RM,Caiozzi GC,Ricketts ML.Dietary procyanidins selectively modulate intestinal farnesoid X receptor-regulated gene expression to alter enterohepatic bile acid recirculation: elucidation of a novel mechanism to reduce triglyceridemia[J].Mol Nutr Food Res,2016,60(4):727-736.[29]Wang H,He Q,Wang G,et al.FXR modulators for enterohepatic and metabolic diseases[J].Expert Opin Ther Pat,2018,28(11):765-782.[30]Pathak P,Liu H,Boehme S,et al.Farnesoid X receptor induces Takeda G-protein receptor 5 cross-talk to regulate bile acid synthesis and hepatic metabolism[]J.J Biol Chem,2017,292(26):11055-11069.[31]Zheng X,Chen T,Jiang R,et al.Hyocholic acid species improve glucose homeostasis through a distinct TGR5 and FXR signaling mechanism[J].Cell Metab,2021,33(4):791-803.e7.[32]Li P,Zhu L,Yang X,et al.Farnesoid X receptor interacts with cAMP response element binding protein to modulate glucagon-like peptide-1 (7-36) amide secretion by intestinal L cell[J].J Cell Physiol,2019,234(8):12839-12846.[33]Xie C,Jiang C,Shi J,et al.An Intestinal Farnesoid X Receptor-Ceramide Signaling Axis Modulates Hepatic Gluconeogenesis in Mice[J].Diabetes,2017,66(3):613-626.[34]Xu X,Shi X,Chen Y,et al.HS218 as an FXR antagonist suppresses gluconeogenesis by inhibiting FXR binding to PGC-1α promoter[J].Metabolism,2018,85:126-138.[35]Hui S,Liu Y,Chen M,et al.Capsaicin Improves Glucose Tolerance and Insulin Sensitivity Through Modulation of the Gut Microbiota-Bile Acid-FXR Axis in Type 2 Diabetic db/db Mice[J].Mol Nutr Food Res,2019,63(23):e1900608.[36]Ibrahim SH,Jonas MM,Taylor SA,et al.Liver Diseases in the Perinatal Period: Interactions Between Mother and Infant[J].Hepatology,2020,71(4):1474-1485.[37]Ovadia C,Perdones-Montero A,Spagou K,et al.Enhanced Microbial Bile Acid Deconjugation and Impaired Ileal Uptake in Pregnancy Repress Intestinal Regulation of Bile Acid Synthesis[J].Hepatology,2019,70(1):276-293.[38]Tang B,Tang L,Li S,et al.Gut microbiota alters host bile acid metabolism to contribute to intrahepatic cholestasis of pregnancy[J].Nat Commun,2023,14(1):1305.[39]Yuan X,Zhou L,Zhang B,et al.Early second-trimester plasma cell free DNA levels with subsequent risk of pregnancy complications[J].Clin Biochem,2019,71:46-51.[40]Axelsen SM,Kampmann U,Koefoed AS,et al.Intrahepatic cholestasis of pregnancy: Association with glycaemic control in gestational diabetes[J].Diabet Med,2021,38(8):e14574.[41]Arafa A,Dong JY.Association between intrahepatic cholestasis of pregnancy and risk of gestational diabetes and preeclampsia: a systematic review and meta-analysis[J].Hypertens Pregnancy,2020,39(3):354-360.[42]Majewska A,Godek B,Bomba-Opon D,et al.Association between intrahepatic cholestasis in pregnancy and gestational diabetes mellitus. A retrospective analysis[J].Ginekol Pol,2019,90(8):458-463.[43]Valencia-Ortega J,González-Reynoso R,Salcedo-Vargas M,et al.Differential Expression of FXR and Genes Involved in Inflammation and lipid Metabolism Indicate Adipose Tissue Dysfunction in Gestational Diabetes[J].Arch Med Res,2023,54(3):189-196.[44]McIlvride S,Nikolova V,Fan HM,et al.Obeticholic acid ameliorates dyslipidemia but not glucose tolerance in mouse model of gestational diabetes[J].Am J Physiol Endocrinol Metab, 2019,317(2):E399-E410.[45]Zi?誰tek M,Celewicz Z,Szczuko M.Short-Chain Fatty Acids, Maternal Microbiota and Metabolism in Pregnancy[J].Nutrients,2021,13(4):1244.[46]Zi?誰tek M,Celewicz Z,Kikut J,et al.Implications of SCFAs on the Parameters of the Lipid and Hepatic Profile in Pregnant Women[J].Nutrients,2021,13(6):1749.[47]Chen T,Zhang Y,Zhang Y,et al.Relationships between gut microbiota, plasma glucose and gestational diabetes mellitus[J].J Diabetes Investig,2021,12(4):641-650.